TVGN
Tevogen Bio Holdings Inc
NASDAQ: TVGN · HEALTHCARE · BIOTECHNOLOGY
$6.64
+3.43% today
Updated 2026-04-30
Market cap
$27.03M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-8.08
Dividend yield
—
52W range
$4 – $76
Volume
0.2M
Tevogen Bio Holdings Inc (TVGN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | $7.66M | $7.74M | $5.51M | $3.46M |
| Cash & equivalents | $7.12M | $5.48M | $1.05M | $1.28M |
| Current assets | $7.17M | $5.84M | $1.72M | $2.36M |
| Total liabilities | $24.15M | $41.69M | $99.93M | $10.14M |
| Current liabilities | $667944.00 | $1.96M | $85.48M | $9.04M |
| Long-term debt | $23.48M | $39.30M | $14.22M | $1.00M |
| Shareholder equity | $-16.49M | $-33.95M | $-94.43M | $-6.67M |
| Retained earnings | $-17.14M | $-39.18M | $-99.66M | $-113.39M |
| Accounts receivable | — | — | $344500.00 | $158819.00 |
| Inventory | — | — | — | — |
| Goodwill | — | — | — | — |